177 Results forOncologists near Shawnee Mission, KS

Care Philosophy: As a member of Physician Services Group, Dr. Singh sees the value of a collaborative environment where he can consult others with expertise in various areas of medicine and does not hesitate to recommend his patients seek out a second opinion. The ability to see the care of an individual patient as a team approach allows patients to receive the best available care. When asked how he views his practice and how he approaches the care of patients and their families, Dr. Singh responded, ?I strive every day to be compassionate in the care that I bring the patient. I explain that they are now part of my family. I will give them the same advice and care that I would my own family members. I will walk through the journey of cancer with them. It is my duty and what I am supposed to do for them.

Biography: Suman Kambhampati, MD, is board-certified in Hematology/Medical Oncology. He is the clinical program director for the Sarah Cannon Transplant and Cellular Therapy Program at Research Medical Center in Kansas, City, MO. Dr. Kambhampati treats patients affected by blood cancers and complex hematology issues. He has led or participated in multiple cancer research studies and published numerous professional papers. Dr. Kambhampati currently serves as Vice-Chair of the Sarah Cannon Blood Cancer Network (SCBCN) Quality Management Committee on Complex Blood Cancers and is involved with teaching and training of trainees at the Kansas City VA Medical Center, where he serves as a staff physician. He is Principal Investigator with the Southwest Oncology Group (SWOG), an affiliate of the National Cancer Institute (NCI), and leads efforts at VA to enroll patients into SWOG/NCI-sponsored clinical trials.Dr. Kambhampati has received multiple awards for both his research and patient care, including the prestigious Alpha Omega Alpha and Lauri Stauss Leukemia Foundation Research Fellow; Department of Veterans Affairs Special Contribution Awards in Clinical Practice, Research and System Redesigns; Kansas NIH COBRE First Award in Cancer Experimental Therapeutics; Kansas City Super Docs in Hematology and Oncology; Appreciation of Exceptional Leadership and Dedication to Oncology from the Association of VA Hematology and Oncology. He is a professional member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the American Association for Cancer Research (AACR), and the Association of Veteran Affairs Hematology & Oncology (AVAHO), of which he served as president. He serves as board member of the Leukemia and Lymphoma Society (LLS).